Robert Burkich, MD, of Chattanooga, Tennessee and Preventive Medicine Anti-Aging & Chelation, Inc., his practice in Ringgold, Georgia, have settled claims under the False Claims Act to resolve allegations that they knowingly submitted false claims to Medicare for medically unnecessary chelation therapy. The United States alleges that between September 2009 and January 2017, Dr. Burkich billed Medicare for administering the chelation drug edetate calcium disodium (EDTA) to Medicare beneficiaries who were not suffering from lead poisoning. EDTA is a rarely used drug that is indicated for use only in individuals suffering from lead poisoning and lead encephalopathy. Medicare has several long-standing rules preventing reimbursement for EDTA when not used for cases of lead poisoning or lead encephalopathy. The United States alleges that Dr. Burkich falsely represented to Medicare that his patients suffered from lead poisoning or other heavy-metal-related diseases to avoid Medicare’s restrictions and obtain reimbursement. Based on these allegations, the US Attorney’s Office for the Northern District of Georgia filed suit against Dr. Burkich and his practice, accusing them of violating the False Claims Act, 31 U.S.C. 3729, et seq.